Liquidia Corp (LQDA) stock
LQDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3075% above fair value
$56.73+0.36 (+0.64%)
Close on Nov 17, 2026Market cap $5.08BP/E 40.8Yield –
Liquidia enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Liquidia's enterprise value was $4.64B on Nov 11, 2026, against $2.68B a year earlier. Over the last 5 years it ranged from $177.08M to $7.20B, with a median of $757.59M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $4.64B | +63.4% |
| 2025 | Dec 31, 2025 | $2.84B | +259.2% |
| 2024 | Dec 31, 2024 | $789.89M | +12.1% |
| 2023 | Dec 29, 2023 | $704.51M | +112.2% |
| 2022 | Dec 30, 2022 | $332.03M | +66.5% |
| 2021 | Dec 31, 2021 | $199.40M | +359.8% |
| 2020 | Dec 31, 2020 | $43.36M | – |
See a number that looks wrong?